Imago BioSciences’ $134.4 Million Initial Public Offering

Latham & Watkins LLP represented Imago BioSciences, Inc. in the offering.Imago BioSciences, Inc. (Imago) (NASDAQ: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now